https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• The time required to consummate the acquisition of the Dyneema business, the satisfaction or waiver of conditions in the purchase agreement, the ability to obtain required regulatory or other third-party approvals and consents and
otherwise consummate the proposed acquisition of the Dyneema business;
• Our ability to achieve the strategic and other objectives relating to the proposed acquisition of the Dyneema business and possible sale of the Distribution business;
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues;
• Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2021 under Item 1A, “Risk Factors.”
As
presented in previous slides, this presents potential benefits with
respect to leverage and EBITDA margins
PEER COMPARISONS
42
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
Source: Peer data per Bloomberg market data as of April 21, 2022
86
82
86 86 84
78 77
89 86
81 80
76 76 76
67 67
11
(12)
A
vi
en
t
A
vi
en
t P
F
F
U
L
K
W
R
P
P
G
R
P
M
A
V
Y
F
M
C
U
N
V
R
B
N
R
H
U
N
H
X
L
E
C
L
C
E
A
S
H
E
M
N
S
C
L
A
LB
12%
18%
16% 15% 15% 14% 14%
28% 28%
26%
25%
22% 21% 19%
16%
12%
9% 9%
A
vi
en
t T
od
ay
A
vi
en
t P
F
A
V
Y
P
P
G
K
W
R
FU
L
R
P
M C
E
A
LB
FM
C
A
S
H
E
C
L
E
M
N
H
X
L
H
U
N
S
C
L
B
N
R
U
N
V
R
Median: 21%Median: 15%
2 0 2 2 E B I T DA M A RG I N S V S .
https://www.avient.com/idea/changing-regulations-ivdr
Additionally, there have been significant deviations from the Directive over time, forcing a departure from the document's original objectives and goals of maintaining the health and safety of IVD devices.
This means that an estimated 80-90% of all IVD applications will need the NB evaluation as compared to 10-20% under the original IVD Directive
https://www.avient.com/sites/default/files/resources/POL%2520KeyBanc%2520IR%2520Presentation%2520w%2520non-GAAP%252009%252010%25202013.pdf
Use of Non GAAP Measures
Page 3
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500
Strategy and Execution Drive Results
Page 4
All time closing high of
$29.48
August 1, 2013
• 15 consecutive quarters of
double digit EPS growth
• 42% CAGR adjusted EPS
expansion 2006-2012
• YTD stock price has
increased 42% versus 20%
growth in the S&P
• 275% increase in market cap:
$0.7b $2.6b since 2006
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
PP&S
15%
Specialty
60%
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
4%
Consumer
9%
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
9%
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 6
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
**Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations
2%
34%
43% 45%
60%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2012 2012 PF** 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $114M $150M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 H1 2013 2015
Where we were Where we are
Organic Consolidated
Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.7% 12.6% 12 – 16%
Global Specialty Engineered
Materials 1.1% 10.9% 9.2% 12 – 16%
Designed Structures & Solutions — — 4.4% 8 – 10%
Performance Products &
Solutions 5.4% 8.1% 8.2% 9 – 12%
Distribution 2.6% 6.1% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 26%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
*Percentage of Specialty Platform revenue from products introduced in last five years
19.5%
46.5%
2006 Q2 2013
$20.3
$44.7
2006 TTM
Q2'13
14.3%
31.1%
2006 Q2 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 9
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 10
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.8
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM for taxes on resin gain
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2025-03/Advanced Composites Utility Poles Product Overview.pdf
KEY PERFORMANCE ADVANTAGES
Southern Yellow Pine1
Equivalent Wood Pole
GridCore FRP Pole2
14 in x .750 in
Length
(ft)
Load
Class3
Allowable Class
Load4 (kip)
Weight
(lb)
Deflection5
(in)
Weight
(lb)
Deflection5
(in)
40
3 1.95 1360 35
1040
12
2 2.41 1580 32 14
1 2.93 1810 30 18
H1 3.51 2050 28 21
H2 4.16 2310 26 25
45
3 1.95 1630 45
1170
17
2 2.41 1880 41 21
1 2.93 2160 38 26
H1 3.51 2450 36 31
H2 4.16 2760 33 37
50
3 1.95 1910 56
1300
24
2 2.41 2210 52 30
1 2.93 2530 48 36
H1 3.51 2880 45 44
H2 4.16 3240 42 52
55
3 1.95 2210 68
1430
33
2 2.41 2550 63 40
1 2.93 2930 58 49
H1 3.51 3320 54 59
H2 4.16 3740 51 70
60
3 1.95 2520 82
1560
43
2 2.41 2910 76 53
1 2.93 3340 70 65
H1 3.51 3790 65 78
H2 4.16 4270 61 92
65
3 1.95 2840 97
1690
56
2 2.41 3290 90 69
1 2.93 3770 83 84
H1 3.51 4280 77 100
H2 4.16 4820 72 119
70
3 1.95 3180 114
1820
71
2 2.41 3690 105 87
1 2.93 4220 97 106
H1 3.51 4790 90 127
H2 4.16 5390 85 150
POLE SELECTION GUIDE
1 Wood properties data are per ANSI O5.1-2022 Table 1.
Stiff., EI (lb-in2 106) 3437 2419 1158
Section Modulus, S (in3) 98.2 69.1 38.6
Allowable Moment, ɸFS (kip-ft) 368 259 145
Cross Sectional area, A (in2) 31.2 21.2 14
Weight (lb/ft) 26.0 17.7 11.4
FRP POLE SECTIONAL PROPERTIES
*Additional pole sizes and features are in development
https://www.avient.com/sites/default/files/resources/PolyOne%25202018%2520Proxy%2520Statement.PDF
Fearon
Lead Director of our Board since May 14, 2015.
The awards that were originally granted to Mr.
The awards that were originally granted to Mr.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Proxy%2520Statement%25202016.pdf
The awards that were originally granted to Ms.
The cash-settled performance units originally granted to Ms.
All of the stock awards that
vested and were settled in 2015 were granted on February 14, 2012 and settled on February 14, 2015.
https://www.avient.com/sites/default/files/2021-08/20210802-business-profile.pdf
: 14/12/1990
Company Type : PRIVATE COMPANY LIMITED BY SHARES
Status : Live Company
Status Date : 14/12/1990
Principal Activities
Activities (I) WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT
(46900)
:
: IMPORT/EXPORT AND SALES OF POLYMERS Description
: Activities (II)
: Description
Capital
CurrencyIssued Share Capital Share TypeNumber of Shares *
(AMOUNT)
694600 SINGAPORE, DOLLARS ORDINARY694600
7200000 UNITED STATES OF AMERICA, DOLLARS ORDINARY7200000
* Number of Shares includes number of Treasury Shares
CurrencyPaid-Up Capital Share TypeNumber of Shares
(AMOUNT)
694600 SINGAPORE, DOLLARS ORDINARY
7200000 UNITED STATES OF AMERICA, DOLLARS ORDINARY
Page 1 of 4
Authentication No. : E21642955A
Date: 02/08/2021
ACCOUNTING AND CORPORATE REGULATORY AUTHORITY
WHILST EVERY ENDEAVOR IS MADE TO ENSURE THAT INFORMATION PROVIDED IS UPDATED AND CORRECT.
LTD. (199006136Z)
(ACRA)
Number Of Shares Currency
COMPANY HAS THE FOLLOWING ORDINARY SHARES HELD AS TREASURY SHARES
Registered Office Address 3 INTERNATIONAL BUSINESS PARK
#04-14/15
NORDIC EUROPEAN CENTRE
SINGAPORE (609927)
:
Date of Address 16/08/2020:
Date of Last AGM : 29/08/2020
Date of Last AR : 26/10/2020
FYE As At Date of Last AR : 31/12/2019
Audit Firms
NAME
ERNST & YOUNG LLP
Amount Secured Chargee(s)
Charges
CurrencyCharge No.
LTD. (199006136Z)
(ACRA)
Source of
Address
ID
Officers/Authorised Representative(s)
Position Held
Nationality/CitizenshipName
Address
Date of Appointment
Director168 JINAN ROAD, BUILDING 10, ROOM 802,
SHANGHAI
CHINA 200021
CHAN LAI YIN S7480587F MALAYSIAN 28/06/2010ACRA
Secretary26 SIMEI STREET 1
#11-08
MELVILLE PARK
SINGAPORE (529947)
LEE WEI HSIUNG S7927166G SINGAPORE CITIZEN 01/12/2009ACRA
Secretary633 JURONG WEST STREET 65
#10-310
SINGAPORE (640633)
Shareholder(s)
Name
Address
ID Nationality/Citizenship
Place of incorporation/
Origin/Registration
Source of
Address
Address Changed
AVIENT CORPORATION T05UF0103G UNITED STATES OF AMERICA ACRA1
33587 WALKER ROAD, AVON LAKE,
OHIO 44012,
UNITED STATES OF AMERICA
Ordinary(Number) Currency
694600 SINGAPORE, DOLLARS
Ordinary(Number) Currency
7200000 UNITED STATES OF AMERICA, DOLLARS
Page 3 of 4
Authentication No. : E21642955A
Date: 02/08/2021
ACCOUNTING AND CORPORATE REGULATORY AUTHORITY
WHILST EVERY ENDEAVOR IS MADE TO ENSURE THAT INFORMATION PROVIDED IS UPDATED AND CORRECT.
https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows;
• Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Masterbatch business, including any expected synergies;
• Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Our ability to consummate and successfully integrate acquisitions;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.”
This
innovation drives performance and is
reflective of consistent, strategic
investments in our portfolio…and
people.
2020 Pro forma $991 $86
Sustainable Solutions 15 11% 6
Healthcare 28 22% 6
Composites 6 10% 3
Growth in Emerging Regions 44 30% 10
Other 53 10% 7
Sub-total $1,137 15% $118
FX Impact 25 - 2
Synergies - - 11
Incentives, Travel, Other Employee Costs - - (8)
2021 Actual $1,162 17% $123
Q1 2021 ORGANIC SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
7
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Sales Growth Rate
Adjusted
Operating
Income$ millions
(1)
8
Electrical &
Electronics
Building &
Construction
Wire & Cable Transportation Industrial Healthcare Packaging Consumer
Q1 2020PF Q1 2021
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(2) Financial information is presented on a constant currency basis
(1,2)
(42% of total revenue)
(58% of total revenue)
Q1 END MARKET SALES PERFORMANCE
+17%
+14% +8%
+10%
+8% +22%
+5%
+24%
Q 2 A N D F U L L Y E A R
2 0 2 1 O U T L O O K
$69
$112
2020PF 2021E
$0.42
$0.80
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – Q2
( T O TA L C O M PA N Y )
10
Sales Adjusted Operating Income
$870
$1,100
2020PF 2021E
+ 26%
Adjusted EPS
+ 62% + 90%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
FULL YEAR GUIDANCE INCREASED
11
Sales Adj.
We will deliver for our stakeholders through multiple value creation levers—many of
which are unique to Avient:
o Demand for sustainable solutions, healthcare, and composites, together with Clariant
Masterbatch revenue synergies, that will drive 2021 revenue growth of 14% and long-term
growth in excess of GDP
o Clariant Masterbatch cost synergy capture will result in significant near-term benefit
In addition, we remain committed to increasing annual dividends in line with earnings growth and
opportunistically buying back shares, all while remaining modestly levered.
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-1
July 14, 2021
July 14, 2021
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-announces-quarterly-dividend-301334137.html
https://www.avient.com/investor-center/news/polyone-corporation-announces-quarterly-dividend-5
February 14, 2018
Feb. 14, 2018
View original content:http://www.prnewswire.com/news-releases/polyone-corporation-announces-quarterly-dividend-300599036.html